Pace® Life Sciences Enhances Efficiency with Labguru Platform for Streamlined Laboratory Operations

Transforming Laboratory Efficiency: Pace® Life Sciences’ Adoption of Labguru Platform

In a significant move towards enhancing operational efficiency, Pace® Life Sciences implements Cenevo’s Labguru platform to revolutionize its documentation processes. As a U.S.-based contract development and manufacturing organization (CDMO) and a provider of good manufacturing practice (GMP) analytical laboratory services, Pace® recognizes the critical need for streamlined workflows in an increasingly competitive marketplace. The Labguru system, an integrated cloud-based laboratory data management platform, consolidates essential tools like electronic lab notebooks (ELN), inventory management, and laboratory information management systems (LIMS) while integrating AI-based informatics tools. This comprehensive digital solution aims to boost compliance, improve data integrity, and enhance the overall client experience.

Cynthia Hansen, the IT Program Director at Pace®, emphasizes the adaptability of the Labguru platform in addressing their unique operational needs. The tailored modules offered by Labguru not only facilitate a smooth transition from manual, paper-based processes to digital workflows but also significantly reduce the potential for human error in data entry. The integration allows scientists to focus on high-priority tasks, thereby enhancing productivity and service quality. Adam Michel, Senior ELN Specialist at Pace®, notes the extensive customization capabilities of Labguru, which tailor the system to their evolving operational processes. Currently, the platform is operational across four GMP analytical service laboratories, with future expansions planned to accommodate Pace®'s growth trajectory.

This collaboration between Pace® and Labguru is more than a technological upgrade; it represents a strategic alignment with regulatory compliance and operational excellence in the pharmaceutical and biopharmaceutical industries. Gal Hasse, VP of Product Labguru at Cenevo, expresses pride in this partnership, highlighting how the AI-enabled platform supports Pace® in scaling its laboratory capabilities and manufacturing services. By embracing such innovative solutions, Pace® Life Sciences is well-positioned to enhance its service offerings and stay competitive in an ever-evolving industry landscape.

In related industry developments, Agilisium announces a notable $5.5 million investment aimed at transforming how pharmaceutical, biotech, and medtech companies adopt AI technology. Central to this initiative is the launch of the "Forward Deployment Experts" (FDX), a professional standard designed to facilitate the integration of AI into life sciences. Agilisium aims to address the challenges of AI adoption by embedding experts directly within client organizations, fostering collaboration across scientific, regulatory, and commercial teams.

Raj Babu, CEO of Agilisium, highlights that the primary barrier to AI adoption in the life sciences sector is not technological but rather the absence of cross-functional talent. By focusing on FDX practitioners, autonomous AI agents, and managed teams, Agilisium seeks to create an operating model that effectively translates AI potential into real-world applications, aiming to position itself at the forefront of AI innovation in the life sciences domain.